[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.107.222. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 1,002
Citations 0
Correction
September 13, 2016

Incorrect Test Characteristic

JAMA. 2016;316(10):1116. doi:10.1001/jama.2016.10856

In the JAMA Diagnostic Test Interpretation entitled “Elevated Hemoglobin or Hematocrit Level,”1 published in the May 24/31, 2016, issue of JAMA, a test characteristic was incorrectly described. The sentence that read as follows: “Typically, JAK2V617F is quantitatively reported as picogram of JAK2V617F per microliter of plasma (Medicare reimbursement cost of testing, $124.87), although qualitative tests are available.” should have read in the following way: “Typically, JAK2V617F is quantitatively reported as a percentage of extracted genomic DNA found to have the point mutation causing JAK2V617F (Medicare reimbursement cost of testing, $124.87), although qualitative tests are available.” This article was corrected online.

References
1.
Scherber  RM, Mesa  RA.  Elevated hemoglobin or hematocrit level. JAMA. doi:10.1001/jama.2016.2435.
×